Literature DB >> 8953111

Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting.

D M Citron1, S Hunt Gerardo, M C Claros, F Abrahamian, D Talan, E J Goldstein.   

Abstract

We isolated 40 strains of Porphyromonas (formerly Bacteroides) species from 29 of 102 cat and dog bite wounds in humans. P. salivosa, P. gingivalis, and P. canoris were the most frequent isolates. A comparison of the RapID ANA II system (Innovative Diagnostic Systems, Norcross, GA), An-IDENT panels (bioMérieux, St. Louis), and API ZYM strips (bioMérieux) showed that the latter kit best characterized these isolates because it included tests for trypsin and chymotrypsin activity; however, the tests for glycosidase activity in this kit were less sensitive than were those in the other kits. None of the biochemical systems was able to identify all species. Arbitrarily primed-polymerase chain reaction fingerprinting with a nonspecific single primer, T3B, yielded distinct profiles for type strains and for the clinical isolates, suggesting that some of the isolates represented previously undescribed species. Growth of these species took > or = 5 days; therefore, laboratories should incubate anaerobic plates from bite wound cultures for > or = 7 days to assure isolation of these common pathogens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953111     DOI: 10.1093/clinids/23.supplement_1.s78

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Dog Bites: Bacteriology, Management, and Prevention.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans.

Authors:  M K Hudspeth; S Hunt Gerardo; D M Citron; E J Goldstein
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 3.  Microbiology of animal bite wound infections.

Authors:  Fredrick M Abrahamian; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.

Authors:  E J Goldstein; D M Citron; C Vreni Merriam; K Tyrrell; Y Warren
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.

Authors:  E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.

Authors:  E J Goldstein; D M Citron; S Hunt Gerardo; M Hudspeth; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

7.  Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.

Authors:  E J Goldstein; D M Citron; C V Merriam; K Tyrrell; Y Warren
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

8.  Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans.

Authors:  E J Goldstein; D M Citron; C V Merriam
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

9.  Pasteurella multocida subsp. multocida and P. multocida subsp. septica differentiation by PCR fingerprinting and alpha-glucosidase activity.

Authors:  S Hunt Gerardo; D M Citron; M C Claros; H T Fernandez; E J Goldstein
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

10.  Management of human and animal bite wound infection: an overview.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.